NCT05458817 (Migrevention) is a NA clinical trial of digital platform in Migraine, sponsored by Tartu University Hospital.

Who is sponsoring NCT05458817?

NCT05458817 is sponsored by Tartu University Hospital.

What drugs are being tested in NCT05458817?

Interventions in NCT05458817: digital platform.

What condition does NCT05458817 study?

NCT05458817 studies Migraine, Primary Headache Disorders.

Is NCT05458817 still recruiting?

NCT05458817 is currently status unknown. Last updated 19 January 2023.

Last reviewed 2023-01-19 · How we verify

NCT05458817: Migrevention

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Digital-technology Based Interventions on Treatment of Migraine.

Status unknown NA Last updated 19 January 2023

What this trial tests

NA trial testing digital platform in Migraine in 600 participants. Status unknown.

Timeline

1 January 2022

Primary endpoint
31 January 2025

31 May 2025

Quick facts

Lead sponsor	Tartu University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	600
Start date	1 January 2022
Primary completion	31 January 2025
Estimated completion	31 May 2025
Sites	1 location across Estonia

Drugs / interventions tested

digital platform

Conditions studied

Migraine — all drugs for Migraine →
Primary Headache Disorders — all drugs for Primary Headache Disorders →

Sponsor

Tartu University Hospital

Who can join

Adults 18 to 64, any sex, with Migraine or Primary Headache Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of the research: To develop an interdisciplinary treatment platform based on digital technology and test the operation and effectiveness of digital interventions in comparison with conventional multidisciplinary treatment or treatment standards (incl. Paper diary, nurse counseling, physiotherapy, cognitive-behavioral therapy).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Implementing a digital solution for patients with migraine-Developing a methodology for comparing digitally delivered treatment with conventional treatment: A study protocol.
Niiberg-Pikksööt T, Laas K, Aluoja A, Braschinsky M. · · 2024 · cited 3× · PMID 38421955 · DOI 10.1371/journal.pdig.0000295

Verify or expand the search:

Other recruiting trials for Migraine

Currently open trials in the same condition.

NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
NCT07487701 — Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study · NA · active not recruiting
NCT07343427 — Impact of GON PRF on Central Sensitization in Migraine Patients · NA · active not recruiting
NCT07336056 — Nerivio Efficacy Under High-Frequency Use · Phase 4 · active not recruiting
NCT07385755 — Desvenlafaxine for Preventive Treatment of Frequent Migraines · NA · active not recruiting

Other Tartu University Hospital trials

Trials by the same sponsor.

NCT06215248 — Myocardial Dysfunction Evaluation in Lower Extremity Arterial Disease Patients With Deformation Analysis · recruiting
NCT06372392 — Universal Fixed Meal Boluses Usage in Patients With Medtronic Minimed 780G Pumps · NA · recruiting
NCT05988541 — Rotator Cuff Integrity and Clinical Outcomes 5 Years After Repair. · NA · completed
NCT05084066 — A Study on the Phenomenon of Remote Ischaemic Preconditioning in Patients With Peripheral Artery Disease · NA · completed
NCT04867499 — Epidemiology of Acute Mesenteric Ischemia · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05458817 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tartu University Hospital
Last refreshed: 19 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05458817.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing